Daniel Lang is Pres Cell Therapy, VP Corp Dev of Athenex, Inc.. Currently has a direct ownership of 81,590 shares of ATNX, which is worth approximately $815. The most recent transaction as insider was on Sep 16, 2022, when has been sold 4,323 shares (Common Stock) at a price of $0.41 per share, resulting in proceeds of $1,772. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 81.6K
0% 3M change
0% 12M change
Total Value Held $815

Daniel Lang Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 16 2022
SELL
Payment of exercise price or tax liability
$1,772 $0.41 p/Share
4,323 Reduced 5.03%
81,590 Common Stock
Sep 16 2022
BUY
Exercise of conversion of derivative security
-
12,500 Added 12.7%
85,913 Common Stock
DL

Daniel Lang

Pres Cell Therapy, VP Corp Dev
Buffalo, NY

Track Institutional and Insider Activities on ATNX

Follow Athenex, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ATNX shares.

Notify only if

Insider Trading

Get notified when an Athenex, Inc. insider buys or sells ATNX shares.

Notify only if

News

Receive news related to Athenex, Inc.

Track Activities on ATNX